Stockreport

Kaskela Law LLC Announces Shareholder Investigation of Protalix BioTherapeutics, Inc. (NYSE: PLX) and Encourages Investors to Contact the Firm

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Protalix BioTherapeutics, Inc. (NYSE: PLX) (“Protalix”) on behalf of the company’s [Read more]